The new grant is based on data collected in the last two years, which allowed Dr. Holoshitz and his team to proceed to functional validation of a new theory.
The focus of this phase is on examining the functional roles of the new mechanism in mouse models of SLE, as well as early translational studies in human cells.
Joseph Holoshitz, M.D.
Professor of Internal Medicine, Division of Rheumatology
Associate Chief for Research